<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01136135</url>
  </required_header>
  <id_info>
    <org_study_id>P081113</org_study_id>
    <secondary_id>2009-A00985-52</secondary_id>
    <nct_id>NCT01136135</nct_id>
  </id_info>
  <brief_title>Cardiac Magnetic Resonance Imaging (CMRI) for Detection of Cardiac Transplant Rejection</brief_title>
  <official_title>Cardiac MRI for the Detection of Cellular Rejection in Patients With Heart Transplantation</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Assistance Publique - Hôpitaux de Paris</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Assistance Publique - Hôpitaux de Paris</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      To find a non-invasive alternative (with using cardiac MRI) to invasive endomyocardial&#xD;
      biopsies for serial detection (EMB) and follow-up of cellular rejection in heart transplant&#xD;
      in childhood.&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Objectives To find a non-invasive alternative (with using cardiac MRI) to invasive&#xD;
      endomyocardial biopsies for serial detection and follow-up of cellular rejection in heart&#xD;
      transplant in childhood.&#xD;
&#xD;
      Background Detection of cardiac rejection is a major problem in cardiac transplantation.&#xD;
      Invasive screenings at predefined time intervals for cellular rejection with using&#xD;
      endomyocardial biopsies are standard procedures. However, cardiac biopsies are distressing&#xD;
      and risky and are also costly. Moreover, as the histological expression of allograft&#xD;
      rejection is patchy, endomyocardial biopsies may lead to sampling error. Thus, as the&#xD;
      sensitivity is low and variable (range for 40 to 95%), indication of biopsy is still of&#xD;
      debate.&#xD;
&#xD;
      Materials and methods All patients who undergone cardiac transplant are potentially eligible.&#xD;
      They will be prospectively included in the study. They will have both examinations, their&#xD;
      routine endomyocardial biopsies and cardiac MRI. Histological diagnosis of cellular rejection&#xD;
      is given by the BILLINGHAM classification which is used in daily practice. Diagnosis of&#xD;
      rejection of cardiac MRI is defined by the association of hyperintensity on T2-weighted&#xD;
      sequence, and on gadolinium-enhanced sequences including SSFP (study state free precession)&#xD;
      and myocardial delayed enhancement. Both MRI parameters attest of the presence of myocardial&#xD;
      oedema related to acute rejection. Myocardial oedema is also associated with segmental&#xD;
      abnormalities of myocardial contraction which is assessed by both CMR-tagged sequence.&#xD;
&#xD;
      Written informed consent will be required from the patients. Institutional review board&#xD;
      approval will also be required.&#xD;
&#xD;
      Expected results and clinical implications We expect to demonstrate that CMRI is effective&#xD;
      for detection of cellular rejection with a high sensitivity (expected sensitivity&gt;95%) as&#xD;
      compared to cardiac biopsy. In that condition, cardiac MRI could replace the invasive biopsy&#xD;
      for serial detection and follow-up of rejection in heart transplant.&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date>February 2010</start_date>
  <completion_date type="Actual">February 2015</completion_date>
  <primary_completion_date type="Actual">January 2015</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Cohort</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>The sensitivity and specificity of cardiac MRI for detecting heart transplant rejection will be calculated. The expected sensitivity and specificity are &gt; 95%.</measure>
    <time_frame>24 MONTHS</time_frame>
  </primary_outcome>
  <number_of_groups>1</number_of_groups>
  <enrollment type="Actual">36</enrollment>
  <condition>Heart Transplant Rejection</condition>
  <arm_group>
    <arm_group_label>CARDIAC MRI</arm_group_label>
  </arm_group>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>CARDIAC MRI</intervention_name>
    <description>To find a non-invasive alternative (with using cardiac MRI) to invasive endomyocardial biopsies for serial detection and follow-up of cellular rejection in heart transplant in childhood.</description>
    <arm_group_label>CARDIAC MRI</arm_group_label>
  </intervention>
  <eligibility>
    <study_pop>
      <textblock>
        Patients who had undergone cardiac transplants&#xD;
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  all patients who had undergone cardiac transplants are eligible&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  no consent&#xD;
&#xD;
          -  allergy to contrast agent (Gadolinium)&#xD;
&#xD;
          -  severe renal failure (clearance &lt; 30ml/min/1.73m²)&#xD;
&#xD;
          -  claustrophobia&#xD;
&#xD;
          -  severe arrhythmias&#xD;
&#xD;
          -  absence of medical care insurance&#xD;
&#xD;
          -  pregnancy&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>N/A</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Ou Phalla, MCU PH</last_name>
    <role>Principal Investigator</role>
    <affiliation>Assistance Publique - Hôpitaux de Paris</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Hopital Necker</name>
      <address>
        <city>Paris</city>
        <zip>75015</zip>
        <country>France</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>France</country>
  </location_countries>
  <verification_date>August 2015</verification_date>
  <study_first_submitted>February 26, 2010</study_first_submitted>
  <study_first_submitted_qc>June 2, 2010</study_first_submitted_qc>
  <study_first_posted type="Estimate">June 3, 2010</study_first_posted>
  <last_update_submitted>August 31, 2015</last_update_submitted>
  <last_update_submitted_qc>August 31, 2015</last_update_submitted_qc>
  <last_update_posted type="Estimate">September 1, 2015</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>Heart transplant rejection</keyword>
  <keyword>cardiac MRI</keyword>
  <keyword>diagnosis</keyword>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

